THRD实时信号 | 通过Getagraph.com最大化利润

购买 109088 min ago

@ $9.00

发出时间: 14 Feb 2024 @ 01:30

回报率: 20.33%

上一信号: Feb 7 - 02:49

上一信号: 出售

回报率: -2.39 %

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):

Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases...

Stats
今日成交量	75 810.00
平均成交量	149 374
市值	441.40M
EPS	$-0.190 ( 2023-11-09 )
下一个收益日期	( $-0.330 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-13.88
ATR14	$0.0300 (0.28%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-11	Holles Natalie C.	Buy	13 558	Common Stock
2024-04-11	Holles Natalie C.	Sell	13 558	Common Stock
2024-04-11	Holles Natalie C.	Sell	13 558	Employee Stock Option (right to buy)
2024-04-04	Person Julie	Sell	1 107	Employee Option Grant (right to buy)
2024-04-04	Person Julie	Buy	1 107	Common Stock

INSIDER POWER
5.37
Last 98 transactions
Buy: 24 902 019 \| Sell: 27 277 881

音量相关性

長: -0.32 (neutral)

短: -0.27 (neutral)

Signal:(51.115) Neutral

Third Harmonic Bio, Inc. 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Third Harmonic Bio, Inc. 相关性 - 货币/商品

0.28
( neutral )

0.83
( strong )

0.00
( neutral )

0.65
( weak )

-0.35
( neutral )

-0.77
( moderate negative )

Third Harmonic Bio, Inc. 财务报表

Annual	2023
营收:	$0
毛利润:	$-35 000.00 (0.00 %)
EPS:	$-0.780

FY	2023
营收:	$0
毛利润:	$-35 000.00 (0.00 %)
EPS:	$-0.780

FY	2022
营收:	$0
毛利润:	$-38 000.00 (0.00 %)
EPS:	$-0.960

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-1.730

Financial Reports:

No articles found.

Third Harmonic Bio, Inc.

Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops THB001, an oral small-molecule KIT inhibitor for the treatment of chronic urticaria, a dermatologic disease driven by mast cell activation that results in red, itchy, painful welts, or hives, as well as for airway and gastrointestinal tract indications. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts.